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Purpose: Infantile nystagmus (IN) is an inherited disorder characterized by bilateral ocular oscillatory movements.
Recently, mutations in FRMD7 were found to be responsible for X-linked idiopathic infantile nystagmus . We investigated
the role of the FRMD7 gene mutations in seven Chinese families with infantile nystagmus.
Methods: Linkage analysis was performed with fluorescently labeled microsatellite markers, DXS1001 and DXS1047.
Analysis of FRMD7 gene mutations was performed by direct sequence to the whole coding regions and exon-intron
boundaries of FRMD7 gene in all affected members in seven families with IN.
Results: Five novel FRMD7 gene mutations, 70 G>T(p.G24W) in exon 2, c.689–690delAG (p.Ser232del) in exon8, c.
782G>A (p.R260Q) and c. 812G>T (p. C271F) in exon 9, and c. 910C>T (R303X) in exon 10, were identified in five of
seven Chinese families with X-linked infantile nystagmus. But we didn’t detect the FRMD7 gene mutation in one of seven
families, although a positive LOD score of 2.42 (θmax=0.1) was obtained at DXS1047 . We also found the same mutation,
which is c. 782G>A (p.R260Q), occurred in two different families.
Conclusions: This is first report that five kinds of FRMD7 gene mutation types occurred in Chinese families with IN,
which further support that FRMD7 gene mutations are the underlying pathogenesis of the molecular mechanism for
infantile nystagmus.
Infantile nystagmus (IN) is a relatively common ocular
motor disorder characterized by rapid to and fro oscillations
of the eyes. It usually presents itself at birth or develops within
the  first  few  months  of  life.  The  etiology  of  infantile
nystagmus is not clear and usually occurs without sensory
defect. This is different from “sensory defect nystagmus,”
which  is  caused  by  inherited  ocular  diseases  including
albinism,  achromatopsia,  Leber  congenital  amaurosis,
congenital cataract, and anterior segment dysgenesis.
Between 7% and 30% of IN patients have a positive
family history [1] in which inheritance may be autosomal
dominant, autosomal recessive, or X-linked. Five congenital
nystagmus  loci  have  been  mapped  including  autosomal
dominant NYS2 on chromosome 6p12 [2] (OMIM 164100),
autosomal dominant NYS3 on chromosome 7p11.2 (OMIM
608345)  [3],  autosomal  dominant  NYS4  on  chromosome
13q31-q22  (OMIM  193003)  [4],  and  X-linked  NYS1  on
chromosome Xp11.4-p11.3 [5] (OMIM 310700) and Xq26-
q27 [6]. X-linked inheritance is suggested to be the most
common mode with incomplete penetrance in females [7].
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Recently,  mutations  in  FRMD7  were  found  to  be
responsible for X-linked infantile nystagmus [8-10,11,]. In
this  study,  we  report  five  novel  mutations  in  FRMD7  in
Chinese families with infantile idiopathic nystagmus.
METHODS
This study was approved by the Ethics Committee of the
Tianjin  Eye  Hospital,  Tianjin,  China  and  was  conducted
according to the Tenets of the Declaration of Helsinki. Seven
families with X-linked infantile idiopathic nystagmus were
investigated  .To  exclude  ocular  or  neural  visual  pathway
abnormalities, a detailed clinical examination including visual
acuities,  slit  examination  of  the  lens,  examination  of  the
vitreous, fundus, electroretinogram (ERG), and visual evoked
potential (VEP)was performed for those patients who could
accept clinical examination at Tianjin Eye Hospital.
After  informed  consent  was  obtained,  a  5  ml  blood
sample was collected from every participant and genomic
DNA was isolated from peripheral blood lymphocytes using
a  DNA  isolation  kit  (Roche  Biochemical  Inc.,  Basel,
Switzerland.).
Linkage analysis was performed on those pedigrees with
a  sufficient  number  of  affected  individuals.  Fluorescently
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733labeled  microsatellite  markers,  DXS1001  and  DXS1047,
were  analyzed  by  polymerase  chain  reaction  (PCR)
amplification in a 10 μl reaction mixture containing 50 ng of
genomic DNA, 1X PCR buffer, 2.0 mM MgCl2, 0.2 mmol/l
of each dNTP, 5 pmol/l of each forward and reverse primer,
and 0.2 U of AmpliTaq Gold DNA polymerase. Markers were
genotyped using an ABI 3130 Genetic Analyzer (Applied
Biosystems, Foster City, CA). Genotypes were analyzed using
the GeneMapper 3.7 Software (Applied Biosystems).
Two-point  LOD  scores  were  calculated  with  easy
Linkage  plus  v4.0  beta  software,  assuming  an  X-linked
dominant trait with 100% penetrance on male and 50% in
female, a disease allele of 0.001, and arbitrary marker allele
frequencies of 1/n with n being the number of alleles observed
for that specific marker.
Mutation  screening  was  performed  by  direct  DNA
sequence  analysis.  Whole  coding  regions  and  exon-intron
boundaries  of  the  FRMD7  gene  were  PCR-amplified  in
50  μl  of  a  standard  PCR  buffer  containing  1.5  mmol/l
MgCl2, 0.2 mmol/l of each dNTP, 0.5 μmol/l of each primer,
1 U of Taq polymerase, and 50 ng of DNA. The amplification
program was an initial 2 min of denaturation at 98 °C followed
by 30 cycles of 30 s at 94 °C, 30 s at 55 °C, 1 min at 72 °C,
and a final 7 min extension step at 72 °C. The PCR products
were  extracted  using  the  QIAquick  Gel  Extraction  Kit
(Qiagen,  Valencia,  CA).  DNA  sequencing  analysis  was
performed using the BigDye Terminator Cycle Sequencing
v3.1 kit on an ABI PRISM 3130 Genetic Analyzer (Applied
Biosystems).  Sequences  were  aligned  using  Chromas
software  (Conor  McCarthy,  Griffith  University,  Brisbane,
Queensland,Australia). The reference cDNA sequence was
obtained from the GenBank database (NM_194277.1), and +1
corresponds to the A of the ATG translation initiation codon.
All four SNPs are in the region 60 kb upstream of the start
of the FRMD7 gene transcript.
RESULTS
Four large families with infantile nystagmus were analyzed
by linkage analysis. In family A (from the Sandong province),
16 of the 46 living family members are affected including 10
males and six females. In addition, three females are obligate
unaffected  carriers.  No  male-to-male  transmission  was
Figure 1. Pedigrees of seven families
with  X-linked  congenital  nystagmus.
Squares indicate males, circles indicate
females,  slashed  symbols  indicate
deceased,  black  symbols  indicate
affected  individuals,  unfilled  symbols
indicate  unaffected  individuals,  and
unaffected,  obligate  carriers  are
represented by a dotted circle.
TABLE 1. SEQUENCE ANALYSIS OF FOUR SNPS IN TWO AFFECTED MALES FROM TWO FAMILIES.
Haplotype Family
SNP
rs2180237 rs1569893 rs2748723 rs2748724
II1 E T G T A
IV1 F C C A C
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734observed. The proband is a nine-year-old girl (Figure 1A,
individual IV12) who had nystagmus since three to four months
after birth. She has a horizontal jerk ocular oscillation and a
face turn to left with the null point to the right. The corrected
visual acuity of both eyes at distance is 1.0. Her father is 32
years old with nystagmus since he was three to four months
old. He has a horizontal ocular oscillation with a torsional
component and with little head posture and head shaking. His
corrected visual acuities for both eyes are 0.5. Other patients
have various reduced visual acuity ranging from 0.2 to 1.0.
Five of them have head posture, and two of them have head
oscillations. The penetrance appears to be complete in males
and about 60% in the females.
Significant LOD scores were obtained with polymorphic
markers  DXS1047  (Zmax=8.55,  θmax=0)  and  DXS1001  (Z
max=5.55, θ  max=0). Direct DNA sequence analysis from all
patients and obligate carriers reveals a c. 812G>T missense
mutation in exon 9, which would result in a substitution of the
cysteine residue at codon 271 by a phenylalanine residue
(C271F, Figure 2A).
In family B (from the Henan province), nine patients
(three males and six females) show horizontal jerk ocular
oscillation.  The  affected  males  have  more  serious  ocular
oscillation than the affected females. Five females are obligate
unaffected  carriers.  The  proband  is  a  nine-year-old  boy
(individual IV2 in Figure 1B) who developed nystagmus at
three to four months of age with 0.7 corrected visual acuity in
Figure 2. Sequencing results of affected
heterozygous females from families A
and D and of affected hemizygous males
from families B, E, F, and G . Five types
of FRMD7 mutations were identified in
six families, which were c. 812G>T (p.
C271F) in family A, c.689–690delAG
(p.Ser232del)  in  family  B,  c.70
G>T(p.G24W) in family D, c. 782G>A
(p.R260Q) in both families E and F, and
c. 910C>T (R303X) in family G.
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735both eyes at distance. His mother is an asymptomatic obligate
carrier.  Other  patients  have  various  reduced  visual  acuity
ranging from 0.4 to 1.0. A significant LOD Score of 3.61
(θmax=0) was obtained with polymorphic marker, DXS1047,
and  a  LOD  score  of  2.03  (θmax=0.1)  was  obtained  with
DXS1001. Direct DNA sequence analysis of FRMD7 from all
patients and obligate carriers revealed a 2 bp deletion (AG,
689–690) in exon 8 that was not present in unaffected family
members (Figure 2B). The deletion is predicted to result in an
aberrant truncated protein.
Family C was from Liaoning province, and 12 patients
(six males and six females) in this family were found with
horizontal jerk ocular oscillations but without head posture.
Three females are obligate unaffected carriers. The proband
is an eight-year-old boy (individual V7 in Figure 1C) who
developed nystagmus at three to four months of age with 0.3
corrected visual acuity of both eyes at distance. Other patients
have various reduced visual acuity ranging from 0.2 to 1.0.
Positive LOD scores of 2.42 (θmax=0.1) and 0.65 (θmax=0.25)
were  obtained  with  polymorphic  markers,  DXS1047  and
DXS1001, respectively. No mutations were detected in the
FRMD7 gene, although all coding regions and exon-intron
boundaries were sequenced.
In Family D (from Wuhan province), eight patients (two
males and six females) show horizontal jerk ocular oscillation.
The proband is a nine-year-old boy (individual III5 in Figure
1D), and his mother is the only asymptomatic obligate carrier
in all the female members of this family. A positive LOD score
of  1.57  (θmax=0)  was  obtained  with  polymorphic  marker
DXS1047, and a LOD score of 1.31 (θmax=0) was obtained
with  DXS1001.  Sequence  analysis  revealed  a  c.  70G>T
missense  mutation  in  exon  2  in  all  patients  and  obligate
carriers, which would result in a substitution of the glycine
residue at codon 24 by a tryptophan residue (Figure 2D).
Families  E  and  F  are  from  Tianjin,  and  there  is  no
indication  by  history  that  they  are  related.  There  is  an
insufficient number of available affected family members in
these two families to provide a significant LOD score. A direct
sequence of all affected patients in families E and F revealed
the same sequence change in exon 9, a c. 782G>A missense
mutation, which would result in substitution of the arginine
residue at codon 260 by a glutamine residue (R260Q, Figure
2E,F).
To examine the possibility of a common origin between
families  E  and  F,  four  single  nucleotide  polymorphisms
(SNPs; rs2180237, rs1569893, rs2748723, and rs2748724) in
and  around  FRMD7  were  genotyped  in  affected  males,
individual II1 of family E and individual IV1 of family F (Table
1).  The  haplotypes  of  these  two  affected  males  and  by
extension that in their respective families is quite distinct. This
suggests  that  the  same  mutation,  R260Q,  occurred
independently in these two families rather than descending
from a common ancestor.
Sequence analysis of all patients and obligate carriers in
family G revealed a c. 910C>T nonsense mutation in exon 10,
which would result in substitution of the arginine residue at
codon 303 by a stop codon (R303X, Figure 2G).
The maximum LOD scores and mutations identified for
each family are shown in Table 2. None of these five mutations
were detected in 50 male and 50 female unaffected control
individuals  when  tested  by  single  strand  conformation
polymorphism (not shown). These results suggest that c.70
G>T (p.G24W) in exon 2, c.689–690delAG (p.Ser232del) in
exon 8, c. 782G>A (p.R260Q) and c. 812G>T (p. C271F) in
exon  9,  and  c.  910C>T  (R303X)  in  exon  10  are  novel
mutations in the FRMD7 gene.
DISCUSSION
In  this  study,  we  identified  five  novel  mutations  in  the
FRMD7 gene. FRMD7, which has 12 exons and encodes 714
residues, is a previously unidentified member of the protein
4.1 superfamily. In situ hybridization experiments show that
the FRMD7 gene is expressed in the ventricular layer of the
forebrain, midbrain, cerebellar primordium, spinal cord, and
the  developing  neural  retina  in  embryos  56  days  post-
ovulation.  In  earlier  embryos  37  days  post-ovulation,  the
expression is restricted to the midbrain and hindbrain, which
are known to influence the motor control of eye movement
[8].
Previously, 32 mutations in the FRMD7 gene have been
identified in different ethnic groups [8-12] including G24R in
exon 2 and C271Y in exon 9, which is similar to G24W and
C271F  identified  in  families  D  and  A,  respectively.  We
TABLE 2. MUTATIONS IN SEVEN FAMILIES AND THE SIGNIFICANT LOD SCORE IN FOUR FAMILIES.
Family Location Mutation Protein Type of mutation Zmax at DXS1047
A exon 9 c. 812G>T p.C271F missense 8.55
B exon 8 689–690delAG p.S232Ffs2 deletion 3.61
C 2.42
D exon 2 c. 70G>T p.G24W missense 1.57
E exon 9 c. 782G>A p.R260Q missense
F exon 9 c. 782G>A p.R260Q missense
G exon 10 c. 910C>T p.R303X nonsense
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736identified  five  novel  mutations  in  all  but  one  family
investigated here, and family C in which no mutation was
identified shows linkage to the FRMD7 region. Missense,
nonsense, and deletion mutations were observed. All changes
we  identified  were  novel  mutations.  The  three  missense
mutations identified are G24W, C271F, and R260Q of which
G24W and C271F occur at known mutation sites but substitute
a different amino acid residue.
The FRMD7 protein is most highly conserved near the
NH2-terminus,  which  includes  the  B41  and  FERM-C
domains. The B41 domain is located at residues 1–192, and
the  FERM-C  domain  is  located  at  residues  186–279  in
FRMD7. Modeling of the core domain of the cytoskeletal
protein 4.1R suggests that mutations at codon 24 and codon
271 are likely to destabilize the protein by the introduction of
larger amino acids within restricted areas of the protein [8].
Multiple alignment of the region shows that codon 24, codon
260,  and  codon  271  are  located  within  highly  conserved
regions  that  are  invariant  in  Canis  familiaris,  Rattus
norvegicus, Mus musculus, and Gallus gallus, suggesting that
these amino acids are critical to the normal function of the
protein (Figure 3).
We also found a nonsense mutation, R303X, in exon 10
and a novel deletion mutation, p.S232Ffs2, in exon 8. Either
of these two changes alters the length of the open reading
frame, creating an aberrant truncated protein.
In one of our familial cases, no mutation was found in the
coding  region  and  exon-intron  boundaries  of  FRMD7,
although FRMD7 was sequenced in all affected males and
females. It is possible that congenital nystagmus in this family
is caused by a mutation located in the promoter or other
regulatory regions including those within introns or that there
might be unknown splice variants that we didn’t detect with
our experiment technique.
As shown by the results above, we have further expanded
the  mutational  spectrum  of  FRMD7  and  confirmed  that
mutations  in  FRMD7  are  a  common  cause  for  X-linked
congenital idiopathic nystagmus, although no mutations have
been detected in a small subset of families mapped on Xq26–
27. Further biochemical studies of the mutations in FRMD7
Figure 3. Alignment of FRMD7 amino acids. The alignment of amino
acids around p.G24, p. R260, and p. C271 of FRMD7 revealed
evolutionary  conservation  of  the  residue  from  Canis  familiaris,
Rattus  norvegicus,  Mus  musculus,  and  Gallus  gallus  to  Homo
sapiens.
will yield insight into its molecular mechanism underlying the
pathogenesis of congenital idiopathic nystagmus.
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